- Home
- LXRX vs DIAX Comparison
LXRX vs DIAX Comparison
Compare LXRX & DIAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.75
Company Overview
Basic Information| Metric | LXRX | DIAX |
|---|---|---|
| Founded | 1995 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 660.9M | 525.1M |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | LXRX | DIAX |
|---|---|---|
| Price | $1.75 | $14.10 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $4.15 | N/A |
| AVG Volume (30 Days) | ★ 2.3M | 76.3K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.93% |
| EPS Growth | ★ 77.78 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $49,803,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 60.24 | N/A |
| 52 Week Low | $0.48 | $13.01 |
| 52 Week High | $1.84 | $15.85 |
Technical Indicators
Market Signals| Indicator | LXRX | DIAX |
|---|---|---|
| Relative Strength Index (RSI) | 58.94 | 30.87 |
| Support Level | $1.07 | $13.73 |
| Resistance Level | $1.81 | $14.45 |
| Average True Range (ATR) | 0.10 | 0.21 |
| MACD | 0.01 | -0.04 |
| Stochastic Oscillator | 72.86 | 10.26 |
Price Performance
Historical Comparison LXRX
DIAX
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
About DIAX Nuveen Dow 30SM Dynamic Overwrite Fund of Beneficial Interest
Nuveen Dow 30sm Dynamic Overwrite Fund is a non-diversified closed-end management investment company. Its investment objective is to seek attractive total return with less volatility than the S&P 500 Index.